Selected research
Industry Research
Vaccine Testing Service Industry Research Report 2026
Market perspective
The global Vaccine Testing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Vaccine Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Vaccine Testing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Vaccine Testing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Vaccine Testing Service include RSSL, Labcorp Drug Development, Charles River Laboratories, PPD, WuXi Biologics, Valneva, IQVIA Laboratories Vaccines, Minaris Advanced Testing and IntoxLab and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Vaccine Testing Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Vaccine Testing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Vaccine Testing Service Market by Company
RSSL
Labcorp Drug Development
Charles River Laboratories
PPD
WuXi Biologics
Valneva
IQVIA Laboratories Vaccines
Minaris Advanced Testing
IntoxLab
Creative Diagnostics
Vaccine Testing Service Segment by Type
Physical and Chemical Testing
Microbial Detection
Immunological Testing
Others
Vaccine Testing Service Segment by Application
Inactivated Vaccine
Subunit Vaccine
Toxoid Vaccine
mRNA Vaccine
Viral Vector Vaccine
Others
Vaccine Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccine Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Vaccine Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Physical and Chemical Testing
- Microbial Detection
- Immunological Testing
- Others
Applications
- Inactivated Vaccine
- Subunit Vaccine
- Toxoid Vaccine
- mRNA Vaccine
- Viral Vector Vaccine
- Others
Companies covered
- RSSL
- Labcorp Drug Development
- Charles River Laboratories
- PPD
- WuXi Biologics
- Valneva
- IQVIA Laboratories Vaccines
- Minaris Advanced Testing
- IntoxLab
- Creative Diagnostics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Vaccine Testing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Physical and Chemical Testing
- 2.2.3 Microbial Detection
- 2.2.4 Immunological Testing
- 2.2.5 Others
- 2.3 Vaccine Testing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Inactivated Vaccine
- 2.3.3 Subunit Vaccine
- 2.3.4 Toxoid Vaccine
- 2.3.5 mRNA Vaccine
- 2.3.6 Viral Vector Vaccine
- 2.3.7 Others
- 2.4 Assumptions and Limitations
3 Vaccine Testing Service Breakdown Data by Type
- 3.1 Global Vaccine Testing Service Historic Market Size by Type (2021-2026)
- 3.2 Global Vaccine Testing Service Forecasted Market Size by Type (2027-2032)
4 Vaccine Testing Service Breakdown Data by Application
- 4.1 Global Vaccine Testing Service Historic Market Size by Application (2021-2026)
- 4.2 Global Vaccine Testing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Vaccine Testing Service Market Perspective (2021-2032)
- 5.2 Global Vaccine Testing Service Growth Trends by Region
- 5.2.1 Global Vaccine Testing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Vaccine Testing Service Historic Market Size by Region (2021-2026)
- 5.2.3 Vaccine Testing Service Forecasted Market Size by Region (2027-2032)
- 5.3 Vaccine Testing Service Market Dynamics
- 5.3.1 Vaccine Testing Service Industry Trends
- 5.3.2 Vaccine Testing Service Market Drivers
- 5.3.3 Vaccine Testing Service Market Challenges
- 5.3.4 Vaccine Testing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Vaccine Testing Service Players by Revenue
- 6.1.1 Global Top Vaccine Testing Service Players by Revenue (2021-2026)
- 6.1.2 Global Vaccine Testing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Vaccine Testing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Vaccine Testing Service Head Office and Area Served
- 6.4 Global Vaccine Testing Service Players, Product Type & Application
- 6.5 Global Vaccine Testing Service Manufacturers Established Date
- 6.6 Global Vaccine Testing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Vaccine Testing Service Market Size (2021-2032)
- 7.2 North America Vaccine Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Vaccine Testing Service Market Size by Country (2021-2026)
- 7.4 North America Vaccine Testing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Vaccine Testing Service Market Size (2021-2032)
- 8.2 Europe Vaccine Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Vaccine Testing Service Market Size by Country (2021-2026)
- 8.4 Europe Vaccine Testing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Vaccine Testing Service Market Size (2021-2032)
- 9.2 Asia-Pacific Vaccine Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Vaccine Testing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Vaccine Testing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Vaccine Testing Service Market Size (2021-2032)
- 10.2 South America Vaccine Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Vaccine Testing Service Market Size by Country (2021-2026)
- 10.4 South America Vaccine Testing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Vaccine Testing Service Market Size (2021-2032)
- 11.2 Middle East & Africa Vaccine Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Vaccine Testing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Vaccine Testing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 RSSL
- 12.1.1 RSSL Company Information
- 12.1.2 RSSL Business Overview
- 12.1.3 RSSL Revenue in Vaccine Testing Service Business (2021-2026)
- 12.1.4 RSSL Vaccine Testing Service Product Portfolio
- 12.1.5 RSSL Recent Developments
- 12.2 Labcorp Drug Development
- 12.2.1 Labcorp Drug Development Company Information
- 12.2.2 Labcorp Drug Development Business Overview
- 12.2.3 Labcorp Drug Development Revenue in Vaccine Testing Service Business (2021-2026)
- 12.2.4 Labcorp Drug Development Vaccine Testing Service Product Portfolio
- 12.2.5 Labcorp Drug Development Recent Developments
- 12.3 Charles River Laboratories
- 12.3.1 Charles River Laboratories Company Information
- 12.3.2 Charles River Laboratories Business Overview
- 12.3.3 Charles River Laboratories Revenue in Vaccine Testing Service Business (2021-2026)
- 12.3.4 Charles River Laboratories Vaccine Testing Service Product Portfolio
- 12.3.5 Charles River Laboratories Recent Developments
- 12.4 PPD
- 12.4.1 PPD Company Information
- 12.4.2 PPD Business Overview
- 12.4.3 PPD Revenue in Vaccine Testing Service Business (2021-2026)
- 12.4.4 PPD Vaccine Testing Service Product Portfolio
- 12.4.5 PPD Recent Developments
- 12.5 WuXi Biologics
- 12.5.1 WuXi Biologics Company Information
- 12.5.2 WuXi Biologics Business Overview
- 12.5.3 WuXi Biologics Revenue in Vaccine Testing Service Business (2021-2026)
- 12.5.4 WuXi Biologics Vaccine Testing Service Product Portfolio
- 12.5.5 WuXi Biologics Recent Developments
- 12.6 Valneva
- 12.6.1 Valneva Company Information
- 12.6.2 Valneva Business Overview
- 12.6.3 Valneva Revenue in Vaccine Testing Service Business (2021-2026)
- 12.6.4 Valneva Vaccine Testing Service Product Portfolio
- 12.6.5 Valneva Recent Developments
- 12.7 IQVIA Laboratories Vaccines
- 12.7.1 IQVIA Laboratories Vaccines Company Information
- 12.7.2 IQVIA Laboratories Vaccines Business Overview
- 12.7.3 IQVIA Laboratories Vaccines Revenue in Vaccine Testing Service Business (2021-2026)
- 12.7.4 IQVIA Laboratories Vaccines Vaccine Testing Service Product Portfolio
- 12.7.5 IQVIA Laboratories Vaccines Recent Developments
- 12.8 Minaris Advanced Testing
- 12.8.1 Minaris Advanced Testing Company Information
- 12.8.2 Minaris Advanced Testing Business Overview
- 12.8.3 Minaris Advanced Testing Revenue in Vaccine Testing Service Business (2021-2026)
- 12.8.4 Minaris Advanced Testing Vaccine Testing Service Product Portfolio
- 12.8.5 Minaris Advanced Testing Recent Developments
- 12.9 IntoxLab
- 12.9.1 IntoxLab Company Information
- 12.9.2 IntoxLab Business Overview
- 12.9.3 IntoxLab Revenue in Vaccine Testing Service Business (2021-2026)
- 12.9.4 IntoxLab Vaccine Testing Service Product Portfolio
- 12.9.5 IntoxLab Recent Developments
- 12.10 Creative Diagnostics
- 12.10.1 Creative Diagnostics Company Information
- 12.10.2 Creative Diagnostics Business Overview
- 12.10.3 Creative Diagnostics Revenue in Vaccine Testing Service Business (2021-2026)
- 12.10.4 Creative Diagnostics Vaccine Testing Service Product Portfolio
- 12.10.5 Creative Diagnostics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst